Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 315,000 | 700,000 | 790,000 | 712,000 | 872,000 |
| Receivables | 1,195,000 | 1,280,000 | 1,293,000 | 1,371,000 | 1,438,000 |
| Inventories | 192,000 | 183,000 | 187,000 | 197,000 | 208,000 |
| TOTAL | $1,898,000 | $2,334,000 | $2,426,000 | $2,475,000 | $2,741,000 |
| Non-Current Assets | |||||
| PPE Net | 1,766,000 | 1,707,000 | 1,664,000 | 1,668,000 | 1,707,000 |
| Investments And Advances | 132,000 | 138,000 | 147,000 | 155,000 | 141,000 |
| Intangibles | 8,312,000 | 8,305,000 | 8,339,000 | 8,369,000 | 8,262,000 |
| Other Non-Current Assets | 729,000 | 739,000 | 736,000 | 775,000 | 760,000 |
| TOTAL | $10,939,000 | $10,889,000 | $10,886,000 | $10,967,000 | $10,870,000 |
| Total Assets | $12,837,000 | $13,223,000 | $13,312,000 | $13,442,000 | $13,611,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 |
| Accounts payable and accrued liabilities | 1,396,000 | 1,447,000 | 1,420,000 | 1,544,000 | 1,600,000 |
| TOTAL | $1,551,000 | $1,602,000 | $1,577,000 | $1,700,000 | $1,753,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,978,000 | 3,980,000 | 3,983,000 | 3,985,000 | 4,010,000 |
| Other Non-Current Liabilities | 1,363,000 | 1,349,000 | 1,286,000 | 1,324,000 | 1,342,000 |
| TOTAL | $5,356,000 | $5,349,000 | $5,285,000 | $5,327,000 | $5,375,000 |
| Total Liabilities | $6,907,000 | $6,951,000 | $6,862,000 | $7,027,000 | $7,128,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 111,323 | 113,888 | 116,606 | 117,365 | 119,455 |
| Common Shares | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 |
| Retained earnings | 8,290,000 | 8,263,000 | 8,083,000 | 7,926,000 | 7,649,000 |
| Other shareholders' equity | 16,000 | 6,000 | 16,000 | 22,000 | 25,000 |
| TOTAL | $5,930,000 | $6,272,000 | $6,450,000 | $6,415,000 | $6,483,000 |
| Total Liabilities And Equity | $12,837,000 | $13,223,000 | $13,312,000 | $13,442,000 | $13,611,000 |